Knowledge support for environmental information on pharmaceuticals: experiences among Swedish Drug and Therapeutics Committees.
Drug and Therapeutics Committees
Environment
Knowledge support
Pharmaceuticals
Recommended medicines
Survey
Journal
BMC health services research
ISSN: 1472-6963
Titre abrégé: BMC Health Serv Res
Pays: England
ID NLM: 101088677
Informations de publication
Date de publication:
12 Jun 2023
12 Jun 2023
Historique:
received:
02
01
2023
accepted:
05
06
2023
medline:
14
6
2023
pubmed:
13
6
2023
entrez:
12
6
2023
Statut:
epublish
Résumé
Two publicly available Swedish knowledge support systems, "Pharmaceuticals and Environment" on Janusinfo.se and Fass.se, provide environmental information on pharmaceuticals. Janusinfo is provided by the public healthcare system in Stockholm and Fass is provided by the pharmaceutical industry. The objectives of this study were to investigate the experiences among Swedish Drug and Therapeutics Committees (DTCs) with using the databases, retrieve development proposals for these, and investigate the DTCs' challenges with working with pharmaceuticals in the environment. A cross-sectional survey with 21 questions, both closed and open-ended, was distributed electronically in March 2022 to Sweden's 21 DTCs. Descriptive statistics and inductive categorization were used for the analysis. A total of 132 respondents from 18 regions filled out the survey. The average regional response rate was 42%. The DTCs used the knowledge supports to consider environmental aspects of pharmaceuticals in their formularies and in education. Respondents were more familiar with Janusinfo compared to Fass but appreciated the availability of both. The DTCs especially valued the concrete proposals for certain active pharmaceutical ingredients on Janusinfo. Respondents requested that all medicinal products have environmental information on Fass. Challenges included lack of data, lack of transparency from the pharmaceutical industry and difficulties considering the environmental aspect of pharmaceuticals in their healthcare practice. Respondents wanted more knowledge, clear messages, and legislation to support their work to reduce the negative environmental impact of pharmaceuticals. This study demonstrates that knowledge supports for environmental information on pharmaceuticals are valuable for the DTCs in Sweden, but the respondents experienced challenges in their work in this field. The study can provide insights to those in other countries interested in considering environmental aspects in their formulary decision-making.
Sections du résumé
BACKGROUND
BACKGROUND
Two publicly available Swedish knowledge support systems, "Pharmaceuticals and Environment" on Janusinfo.se and Fass.se, provide environmental information on pharmaceuticals. Janusinfo is provided by the public healthcare system in Stockholm and Fass is provided by the pharmaceutical industry. The objectives of this study were to investigate the experiences among Swedish Drug and Therapeutics Committees (DTCs) with using the databases, retrieve development proposals for these, and investigate the DTCs' challenges with working with pharmaceuticals in the environment.
METHODS
METHODS
A cross-sectional survey with 21 questions, both closed and open-ended, was distributed electronically in March 2022 to Sweden's 21 DTCs. Descriptive statistics and inductive categorization were used for the analysis.
RESULTS
RESULTS
A total of 132 respondents from 18 regions filled out the survey. The average regional response rate was 42%. The DTCs used the knowledge supports to consider environmental aspects of pharmaceuticals in their formularies and in education. Respondents were more familiar with Janusinfo compared to Fass but appreciated the availability of both. The DTCs especially valued the concrete proposals for certain active pharmaceutical ingredients on Janusinfo. Respondents requested that all medicinal products have environmental information on Fass. Challenges included lack of data, lack of transparency from the pharmaceutical industry and difficulties considering the environmental aspect of pharmaceuticals in their healthcare practice. Respondents wanted more knowledge, clear messages, and legislation to support their work to reduce the negative environmental impact of pharmaceuticals.
CONCLUSIONS
CONCLUSIONS
This study demonstrates that knowledge supports for environmental information on pharmaceuticals are valuable for the DTCs in Sweden, but the respondents experienced challenges in their work in this field. The study can provide insights to those in other countries interested in considering environmental aspects in their formulary decision-making.
Identifiants
pubmed: 37309002
doi: 10.1186/s12913-023-09646-7
pii: 10.1186/s12913-023-09646-7
pmc: PMC10259041
doi:
Substances chimiques
Ditiocarb
99Z2744345
Pharmaceutical Preparations
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
618Informations de copyright
© 2023. The Author(s).
Références
Environ Sci Technol. 2020 Apr 7;54(7):4110-4120
pubmed: 32208629
Proc Natl Acad Sci U S A. 2022 Feb 22;119(8):
pubmed: 35165193
J Clin Nurs. 2007 Feb;16(2):234-43
pubmed: 17239058
Br J Clin Pharmacol. 2020 Jan;86(1):10-12
pubmed: 31625180
Expert Rev Pharmacoecon Outcomes Res. 2009 Feb;9(1):65-83
pubmed: 19371180
BMJ Open. 2017 May 2;7(4):e014345
pubmed: 28465306
Environ Toxicol Chem. 2022 Jun 30;:
pubmed: 35770719
Curr Environ Health Rep. 2016 Jun;3(2):153-60
pubmed: 27068434
J Hazard Mater. 2007 Sep 30;148(3):751-5
pubmed: 17706342
Eur J Clin Pharmacol. 2020 Aug;76(8):1151-1160
pubmed: 32388641
Environ Toxicol Chem. 2016 Apr;35(4):823-35
pubmed: 26666847
Sci Total Environ. 2010 May 1;408(11):2327-39
pubmed: 20206966
Eur J Clin Pharmacol. 2018 Jan;74(1):131-138
pubmed: 29063149
Regul Toxicol Pharmacol. 2020 Mar;111:104571
pubmed: 31893528
Eur J Clin Pharmacol. 2013 May;69 Suppl 1:79-87
pubmed: 23640192
Br J Clin Pharmacol. 2022 Dec;88(12):5074-5082
pubmed: 36000992
Bull World Health Organ. 2021 Apr 1;99(4):319-320
pubmed: 33953450